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Mitochondrial diseases are a group of disorders caused mainly by the impairment of
the mitochondrial oxidative phosphorylation process, due to mutations either in the
mitochondrial or nuclear genome. Among them, the mitochondrial neuro-
gastrointestinal encephalo-myopathy (MNGIE) syndrome affects adolescents or young
adults, and is mostly caused by TYMP mutations encoding a cytosolic thymidine
phosphorylase (TP).
Patients and methods
The present study reports the molecular investigation by next-generation re-
sequencing of 281 nuclear genes, encoding mitochondrial proteins, of consanguineous
family including two individuals with MNGIE syndrome associated to optic atrophy.
Bioinformatic analysis was also performed in addition to mtDNA deletion screening
and mtDNA copy number quantification in blood of the two patients which were
carried out by solf clipping program and qPCR respectively.
Results
Next-generation re-sequencing revealed a novel homozygous c.2391G > T POLG
mutation (p.M797I) co-occurring with the hypomorphic c.1311A > G OPA1 variant
(p.I437M). Analysis of the mitochondrial genome in the two patients disclosed mtDNA
depletion in blood, but no deletion. Bio-informatics investigations supported the
pathogenicity of the novel POLG mutation that is located in the C-terminal subdomain
and might change POLG 3D structure, stability and function.
Conclusion
The novel homozygous p.M797I POLG mutation is responsible for MNGIE combined to
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